mygluco.com "now it's easier to take care of yourself"

Population

Children ages 8 – 15 in South Texas with Type 1 Diabetes

• Improved patient-provider communication;
• Proactive intervention care model determined to be feasible;
• At least one Emergency Department admission averted (ie - $6k - $8k saved for the patient's health plan);
• High patient satisfaction reported;
• Identified need for further automation of the patient's blood sugar transmission technology; and,
• Determined that carrier managed long-range wireless networks must be utilized as the transmission medium due to quality and remote diagnostic scenarios experienced during the pilot.

Description

Feasibility trial to investigate use of wireless devices for two-way communication in the care and treatment of diabetes.

Principal Investigator

Stephen W. Ponder MD, CDE, FAAP and Professor of Pediatrics Texas A&M

Trial Sponsor

Type1 Technology Ventures, LLC

Technology

Designed GlucoMON prototype wireless blood sugar transmission device, interactive text messaging/email, online blood sugar charting for both individual and peer group, established care management models around patient-centric teams

Education

Standard clinic training

Duration

July 2002 – April 2003

Participants

11

Outcomes

Patient satisfaction, provider satisfaction, technology & human factors design requirements for optimization

Publication Status

Poster Presentation at 2^nd Annual Diabetes Technology Meeting, November 2003

Back to Clinical Trial Experience Page